Cost-Utility Analysis of Dapagliflozin Versus Saxagliptin Treatment as Monotherapy or Combination Therapy as Add-on to Metformin for Treating Type 2 Diabetes Mellitus

作者：Shanshan Hu, Xun Deng, Yanjiao Ma, Zhilei Li, Yuhang Wang, Yong Wang, Yong Wang, Yong Wang · 发表于：Applied Health Economics and Health Policy · 年份：2020 · DOI：10.1007/s40258-020-00603-7 · 被引用次数：22 · 研究领域：Diabetes Treatment and Management、Metabolism, Diabetes, and Cancer、Diabetes Management and Research